Indaco Venture Partners
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Nouscom | Oct 2026Participated | $135 MSeries D | |
Cortilia | Sep 2026Participated | $12 MOther Equity | |
Golgenia | Aug 2026Participated | $2 MSeries A | |
WISE | Jun 2026Participated | $34 MSeries D | |
Newcleo | Feb 2026Participated | $85 MOther Equity | |
CamGraPhIC | Mar 2025Led | $29 MSeries A | |
Valo Therapeutics | Mar 2025Led | $22 MOther Equity | |
Newronika | Feb 2025Participated | $16 MSeries B | |
WISE | Jul 2024Participated | $27 MSeries D | |
MicThera | May 2024Led | $1 MOther Equity | |
Nouscom | Mar 2024Participated | $8 MSeries C | |
D-Orbit | Jan 2024Participated | $110 MSeries C | |
Nouscom | Oct 2026Participated | $135 MSeries D | |
Cortilia | Sep 2026Participated | $12 MOther Equity | |
Golgenia | Aug 2026Participated | $2 MSeries A | |
WISE | Jun 2026Participated | $34 MSeries D | |
Newcleo | Feb 2026Participated | $85 MOther Equity | |
CamGraPhIC | Mar 2025Led | $29 MSeries A | |
Valo Therapeutics | Mar 2025Led | $22 MOther Equity | |
Newronika | Feb 2025Participated | $16 MSeries B | |
WISE | Jul 2024Participated | $27 MSeries D | |
MicThera | May 2024Led | $1 MOther Equity | |
Nouscom | Mar 2024Participated | $8 MSeries C | |
D-Orbit | Jan 2024Participated | $110 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 2 | 5 |
| Series B | 1 | 2 |
| Series C+ | 0 | 7 |
| Other Equity | 3 | 6 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| May '19 | 1 |
| Jun '19 | 1 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 2 |
| Oct '19 | 1 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 1 |
| Aug '20 | 1 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 2 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 2 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 1 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 2 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 1 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 1 |
| Mar '25 | 2 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 1 |
| Oct '26 | 1 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 17 |
| Space & Frontier Tech | 7 |
| Hardware & Robotics | 4 |
| Professional Services | 4 |
| E-Commerce & Retail | 3 |
| Marketing & Advertising | 3 |
| Manufacturing | 3 |
| Food & Agriculture | 3 |
| Enterprise Software | 2 |
| Cybersecurity & Privacy | 2 |
| Transportation & Logistics | 2 |
| Government & Defense | 1 |
| Clean Energy & Sustainability | 1 |
| Consumer & Lifestyle | 1 |
| Networks, Cloud & Communication | 1 |
| Media & Entertainment | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 3 |
| $5M-$10M | 7 |
| $10M-$25M | 6 |
| $25M-$50M | 7 |
| $50M-$100M | 2 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 25 |
| United States | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| CDP Venture Capital | 6 |
| Panakes Partners | 4 |
| Angelini Ventures | 3 |
| ENEA Tech e Biomedical | 3 |
| Five Seasons Ventures | 3 |
| Primo Ventures | 3 |
| Sofinnova Partners | 3 |
| 5AM Ventures | 2 |
| AbbVie Ventures | 2 |
| Andera Partners | 2 |
| Banca Profilo | 2 |
| Banor SIM | 2 |
| Bpifrance | 2 |
| EIFO | 2 |
| EQT Life Sciences (LSP) | 2 |
| EUREKA! Venture SGR | 2 |
| European Investment Bank | 2 |
| F3F | 2 |
| Genextra | 2 |
| Innogest | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 6 | 22% |
| Participating | 21 | 78% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 33% |
| Co-led | 4 | 67% |
Team
Co-Founder, Investment Director & Board Member
Partner
Investment Manager
Managing Director and Founder
Venture Partner
Partner Indaco Biotech Fund
Chief Financial Officer
Venture Partner